Navigation Links
Genmab Announces 2008 First Quarter Results
Date:5/28/2008

s a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using cutting-edge antibody technology, Genmab's world class discovery, development and manufacturing teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors. Genmab is not under an obligation to up-date statements regarding the future following the publication of this release; nor to confirm such statements in relation to actual results, unless this is required by la
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Passing of Genmab A/S Annual General Meeting
2. Genmab A/S - Notice to Convene Annual General Meeting
3. Genmabs 2007 Annual Report
4. Genmab Announces Year End 2007 Financial Results
5. Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
6. Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
7. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Genmabs Financial Calendar for 2008
10. Genmab Reaches Milestones in Ofatumumab Collaboration
11. Genmab Announces HuMax-CD32b Pre-Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... WASHINGTON, New York , September 23, 2014 ... ), a leading provider of  Closed System Transfer   ... a new exclusive partnership with Taiwanese distributor MedFront Medical Technology ... regulatory bodies in Taiwan , ... for approval as the company continues to expand ...
(Date:9/23/2014)... NY (PRWEB) September 23, 2014 Marktech ... of deep ultra violet emitters in the 280 nm ... standard UV emitters which range from 280nm to 405nm. ... and water sanitation as well as curing. Mark Campito, ... line of special interest to manufacturers is that we ...
(Date:9/23/2014)... 2014 Healthcare professionals, patients ... convene at the Society for Integrative Oncology ... October 26-28 in Houston, Texas to discuss ... in individualized integrative cancer care. This multi-disciplinary ... nutritionists, naturopaths, acupuncturists, and other complementary care ...
(Date:9/23/2014)... September 23, 2014 New ... Imperial Innovations, Cambridge Innovation Capital and Johnson & ... cancer genomics company focused on harnessing the potential ... cancer testing and treatment, today announced it has ... Imperial Innovations and including Cambridge Innovation Capital and ...
Breaking Biology Technology:Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2Marktech Introduces its New Line of Deep UV Emitters 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4
... AMGN ) today announced that results from several ... global burden of osteoporosis, will be presented at the 2010 ... in Toronto, Ontario from Oct. 15-19, 2010.   ... is reinforced by data that will be presented at this ...
... that a new market research report is available in ... http://www.reportlinker.com/p0312814/ Photovoltaic-Technology-Roadmap.html STRATEGIES ... of clean and renewable energy is the main goal ... agreed on a 20% renewable energy target by 2020, ...
... Ganeden Biotech, Inc. , maker of the patented probiotic strain ... 100th patent, which expands the use and scope of the ... bacteria and to better improve digestive and immune health.   ... Ganeden,s latest collaboration with Organic Milling marking a ...
Cached Biology Technology:Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 2Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 3Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 4Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 5Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 6Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 7Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 8Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting 9Reportlinker Adds Photovoltaic Technology Roadmap 2Reportlinker Adds Photovoltaic Technology Roadmap 3Reportlinker Adds Photovoltaic Technology Roadmap 4Ganeden Biotech Granted 100th Probiotic Patent 2
(Date:9/22/2014)... cut grass in recent years has been identified as ... says the aroma also summons beneficial insects to the ... plant signals the environment via the emission of volatile ... for parasitic wasps to come to the plant that ... insect," said Dr. Michael Kolomiets, Texas A&M AgriLife Research ...
(Date:9/22/2014)... have discovered a key molecular cog in a plant,s ... circadian (daily) rhythms based on temperature. , Transcription factors, ... on external stresses such as light, rain, soil ... of researchers at USC has isolated one, called FBH1, ... and there as needed while in keeping it on ...
(Date:9/22/2014)... Brain & Behavior Research Foundation today ... Investigator Grants valued at more than $12.7 ... promising young scientists. Recipients of the $30,000+/year, ... seek to identify causes, improve treatments and ... affect one in four people, including anxiety, ...
Breaking Biology News(10 mins):Mown grass smell sends SOS for help in resisting insect attacks, researchers say 2Mown grass smell sends SOS for help in resisting insect attacks, researchers say 3Genetic switch regulates a plant's internal clock based on temperature 2Brain & Behavior Research Foundation awards 200 NARSAD Young Investigator grants 2
... novel method of collecting and storing carbon dioxide that will ... The quest to capture carbon dioxide is crucial to ... compressed and safely stored. It is also a ... and require several stages of refining and extraction before a ...
... antibiotic and anti-cancer chemicals may one day be synthesised ... that combine to provide soldier beetles with their potent ... Sweden,s Karolinska Institute, published details of the gene identification ... Nature Communications ., "For the first time, our ...
... skin and well-armored bodies. So it comes as something of a ... the most acute in the animal kingdom. The crocodilian sense ... that dot their skin all over their body. In alligators, the ... study, published in the Nov. 8 issue of the Journal ...
Cached Biology News:Capturing carbon with clever trapdoors 2Gene find turns soldier beetle defence into biotech opportunity 2Despite their thick skins, alligators and crocodiles are surprisingly touchy 2Despite their thick skins, alligators and crocodiles are surprisingly touchy 3